BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Dec 5, 2025; 16(4): 110843
Published online Dec 5, 2025. doi: 10.4292/wjgpt.v16.i4.110843
Table 3 Studies showing therapeutic role of enteric nervous system on gastrointestinal motility disorders
No.
Ref.
Study characteristics
Key role of ENS
1Bessard et al[112]Investigates alterations in prostanoid expression and intestinal epithelial barrier functions that contribute to ileusHighlights how disruptions in ENS signaling and epithelial function lead to impaired motility and ileus development
2Bonaz[113]Discusses the role of enteric neuropathy and the vagus nerve in gastrointestinal disorders, with therapeutic implicationsExplores how enteric neuropathy and vagal signaling impact gut function, offering insights into treatment strategies
3Brun et al[114]Studies how Toll-like receptor-2 regulates glial-derived neurotrophic factor production in intestinal smooth muscle cellsFocuses on how glial cells in the ENS influence smooth muscle function and gut motility via neurotrophic factor production
4Ferreira-Duarte et al[115]Explores the interaction between the renin-angiotensin system and enteric neurotransmission in colonic dysmotility in TNBS-induced colitisHighlights the interplay between systemic signaling and the ENS, leading to dysmotility in inflammatory conditions like colitis
5Filpa et al[116]Investigates the role of glutamatergic neurotransmission in the ENS and its role in the brain-gut axis in health and diseaseExplores how glutamate signaling in the ENS influences gut-brain communication and impacts gastrointestinal disorders
6Floettmann et al[117]Provides the pharmacological profile of Naloxegol, a peripherally acting μ-opioid receptor antagonist for opioid-induced constipationFocuses on the interaction between opioid receptors in the ENS and peripheral opioid antagonism to treat constipation
7Gao et al[118]Investigates μ-opioid receptor-mediated enteric glial activation in morphine-induced constipationHighlights the activation of enteric glia through opioid receptors, contributing to constipation in opioid use
8Sanger et al[119]Discusses the role of ghrelin and motilin control systems in gastrointestinal physiology and therapeuticsExplores the control of gastrointestinal motility via ghrelin and motilin systems, which interact with the ENS for motility regulation
9Stakenborg et al[120]Reviews pathophysiology and current therapeutic approaches to postoperative ileusDiscusses how the ENS is involved in the pathophysiology of ileus and how therapies targeting ENS dysfunction can improve recovery


Write to the Help Desk